Live feed07:17:51·1066dANALYSTRatingvia QuantisnowNeurocrine Biosciences upgraded by SVB Securities with a new price targetByQuantisnow·Wall Street's wire, on your screen.NBIX· Neurocrine Biosciences Inc.Health CareOriginal source